Institute for Applied Cancer Science
In The News
The Cancer Prevention and Research Institute of Texas recently announced a major grant funding award to boost the Institute's drug discovery efforts. Read press release.
Who We Are
The Institute for Applied Cancer Science focuses on accelerating the delivery of new, safe and highly effective therapeutics for cancer patients.
It brings together renowned scientists from around the world and MD Anderson’s 18,000-strong “strike force” against cancer. Blending the best attributes of academic and industrial research, it will identify and validate new cancer targets, convert that scientific knowledge into new drugs and advance them into clinical trials.
It’s a unique organization, integrating genomic information, deep-target biology and drug discovery within one team. Its single vision – to radically improve survival rates for people who suffer from several major cancers within the next 10 years – is a major assault in the fight against cancer.
Our Approach
-
Diverse Expertise
Our scientists share expertise in cancer biology, cancer genomics, clinical trials, computational science and bioinformatics, drug discovery, genetics and pharmacology.
-
Cross-Functional Research
Experts from academia and industry are working together with pharmaceutical industry research and development groups to overcome barriers to drug discovery and delivery.
-
Dynamic Environment
Based in a modern facility within The University of Texas Research Park, the Institute is in an area considered an incubator for academic and commercial biotechnology.
